Europe Specialty Generics Market Size & Outlook, 2022-2030

The specialty generics market in Europe is expected to reach a projected revenue of US$ 41,791.7 million by 2030. A compound annual growth rate of 10.2% is expected of Europe specialty generics market from 2023 to 2030.
Revenue, 2022 (US$M)
$19,267.6
Forecast, 2030 (US$M)
$41,791.7
CAGR, 2023 - 2030
10.2%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe specialty generics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe specialty generics market highlights

  • The Europe specialty generics market generated a revenue of USD 19,267.6 million in 2022.
  • The market is expected to grow at a CAGR of 10.2% from 2023 to 2030.
  • In terms of segment, injectables was the largest revenue generating type in 2022.
  • Injectables is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.


Europe data book summary

Market revenue in 2022USD 19,267.6 million
Market revenue in 2030USD 41,791.7 million
Growth rate10.2% (CAGR from 2023 to 2030)
Largest segmentInjectables
Fastest growing segmentInjectables
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInjectables, Oral, Others Type
Key market players worldwideTeva Pharmaceutical Industries Ltd, Viatris Inc, Novartis AG ADR, Hikma Pharmaceuticals PLC, Mallinckrodt PLC Ordinary Shares - New, Bausch Health Companies Inc, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Apotex Inc., Sun Pharmaceutical Industries, Fresenius Kabi AG, STADA Arzneimittel AG


Other key industry trends

  • In terms of revenue, Europe region accounted for 27.6% of the global specialty generics market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 35,366.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Specialty Generics Market Companies

Name Profile # Employees HQ Website
STADA Arzneimittel AG View profile 10001+ Bad Vilbel, Hessen, Germany, Europe http://stada.com
Fresenius Kabi AG View profile 10001+ Bad Homburg, Hessen, Germany, Europe https://www.fresenius-kabi.com
Apotex Inc. View profile 10001+ Toronto, Ontario, Canada, North America http://www.apotex.com
Hikma Pharmaceuticals PLC View profile 2150 1 New Burlington Place, London, United Kingdom, W1S 2HR https://www.hikma.com
Bausch Health Companies Inc View profile 20270 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 https://www.bauschhealth.com
Endo Pharmaceuticals View profile 1001-5000 Ballsbridge, Dublin, Ireland, Europe http://www.endo.com
Mallinckrodt PLC Ordinary Shares - New View profile 2700 College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 https://www.mallinckrodt.com
Viatris Inc View profile 38000 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 https://www.viatris.com
Dr. Reddy’s Laboratories View profile 10001+ Hyderabad, Andhra Pradesh, India, Asia http://www.drreddys.com/
Sun Pharmaceutical Industries View profile 10001+ Mumbai, Maharashtra, India, Asia http://www.sunpharma.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Europe specialty generics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to specialty generics market will help companies and investors design strategic landscapes.


Injectables was the largest segment with a revenue share of 64.23% in 2022. Horizon Databook has segmented the Europe specialty generics market based on injectables, oral, others type covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe specialty generics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe specialty generics market databook

  • Our clientele includes a mix of specialty generics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe specialty generics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe specialty generics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe specialty generics market size, by country, 2018-2030 (US$M)

Europe Specialty Generics Market Outlook Share, 2022 & 2030 (US$M)

Europe specialty generics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online